Order Article Reprints

Feeney L, Jain Y, Beasley M, Donnelly O, Kong A, Moleron R, Nallathambi C, Rolles M, Sanghera P, Tin A, et al. Centralised RECIST Assessment and Clinical Outcomes with Lenvatinib Monotherapy in Recurrent and Metastatic Adenoid Cystic Carcinoma. Cancers. 2021; 13(17):4336. https://doi.org/10.3390/cancers13174336

Feeney, Laura, Yatin Jain, Matthew Beasley, Oliver Donnelly, Anthony Kong, Rafael Moleron, Chandran Nallathambi, Martin Rolles, Paul Sanghera, Aung Tin, and et al. 2021. "Centralised RECIST Assessment and Clinical Outcomes with Lenvatinib Monotherapy in Recurrent and Metastatic Adenoid Cystic Carcinoma" Cancers 13, no. 17: 4336. https://doi.org/10.3390/cancers13174336

Feeney, L., Jain, Y., Beasley, M., Donnelly, O., Kong, A., Moleron, R., Nallathambi, C., Rolles, M., Sanghera, P., Tin, A., Ulahannan, D., Walter, H. S., Webster, R., & Metcalf, R. (2021). Centralised RECIST Assessment and Clinical Outcomes with Lenvatinib Monotherapy in Recurrent and Metastatic Adenoid Cystic Carcinoma. Cancers, 13(17), 4336. https://doi.org/10.3390/cancers13174336